Research and Innovation

Twenty five young people came to Great Ormond Street Hospital’s (GOSH) new digital hub DRIVE last week as part of an event to help digital researchers and industry engage with a diverse group of young people and hear how their products could be improved to better meet young people's needs.

Over 150 people came along to the National Institute for Health Research (NIHR) GOSH Biomedical Research Centre showcase last month to hear about our latest research highlights - from cutting edge CAR-T therapies for leukaemia, to Oculome genomic sequencing to diagnose rare childhood eye conditions.

GOSH and UCL Great Ormond Street Institute of Child Health (ICH) researchers Professor Paul Gissen and Dr Julien Baruteau will be part of a new collaboration with Evox Therapeutics that aims to develop a new therapy for the life threatening metabolic condition, argininosuccinic aciduria (ASA)

A cutting-edge research project applying the next generation of genome editing to treat aggressive childhood leukaemia has received over £1.4 million of funding from UK Research and Innovation.

Four UCL Great Ormond Street Institute of Child Health researchers have been awarded research grants from Great Ormond Street Hospital Children’s Charity and Sparks, the children’s medical research charity as part of their annual National Call. 

Two allied health professionals (AHPs) at Great Ormond Street Hospital (GOSH) have been awarded prestigious Clinical Doctoral Fellowships from the National Institute for Health Research (NIHR).

GOSH nurse Dr Kate Oulton is to become part of a brand new nurse and midwife research leadership programme - the National Institute for Health Research’s (NIHR) 70@70 Research Leader programme.

Genetic sequencing improved the diagnosis of abnormalities detected in ultrasound scans of developing babies, in new research from Great Ormond Street Hospital (GOSH), the Wellcome Sanger Institute and Birmingham Women’s Hospital.

An 11-year-old boy has become the first NHS patient to receive a pioneering new cancer therapy at Great Ormond Street Hospital (GOSH).

A new, targeted treatment for the rare form of rickets called X-Linked Hypophosphataemia (XLH) is now available to NHS patients from 8 January 2019, following an international clinical trial.